AAAAAA

   
Results: 1-8 |
Results: 8
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens
Authors: Lopez, H Vilches, V Scarano, S Stepanik, D Smayevsky, J Lemme, L Cardenosa, O Ambler, J Sucari, A
Citation: H. Lopez et al., Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens, INT J ANT A, 18(4), 2001, pp. 379-382
The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position
Authors: Baettig, U Brown, L Brundish, D Dell, C Furzer, A Garman, S Janus, D Kane, PD Smith, G Walker, CV Cockcroft, XL Ambler, J Mitchelson, A Talbot, MD Tweed, M Wills, N
Citation: U. Baettig et al., The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position, BIOORG MED, 10(14), 2000, pp. 1563-1566
The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors
Authors: Hayler, J Kane, PD LeGrand, D Lugrin, F Menear, K Price, R Allen, M Cockcroft, XL Ambler, J Butler, K Dunnet, K Mitchelson, A Talbot, M Tweed, M Wills, N
Citation: J. Hayler et al., The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors, BIOORG MED, 10(14), 2000, pp. 1567-1570
Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G
Authors: Ambler, J Brown, L Cockcroft, XL Grutter, M Hayler, J Janus, D Jones, D Kane, P Menear, K Priestle, J Smith, G Talbot, M Walker, CV Wathey, B
Citation: J. Ambler et al., Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G, BIOORG MED, 9(9), 1999, pp. 1317-1322
The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore
Authors: Ambler, J Bentley, D Brown, L Dunnet, K Farr, D Janus, D Le Grand, D Menear, K Mercer, M Talbot, M Tweed, M Wathey, B
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore, BIOORG MED, 9(8), 1999, pp. 1103-1108
Studies towards the identification of potent, selective and bioavailable thrombin inhibitors
Authors: Ambler, J Baker, E Bentley, D Brown, L Butler, K Butler, P Farr, D Dunnet, K Le Grand, D Hayler, J Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., Studies towards the identification of potent, selective and bioavailable thrombin inhibitors, BIOORG MED, 9(5), 1999, pp. 737-742
Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency
Authors: Brundish, D Bull, A Donovan, V Fullerton, JD German, SM Hayler, JF Janus, D Kane, PD McDonnell, M Smith, GP Wakeford, R Walker, CV Howarth, G Hoyle, W Allen, MC Ambler, J Butler, K Talbot, MD
Citation: D. Brundish et al., Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency, J MED CHEM, 42(22), 1999, pp. 4584-4603
The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668
Authors: Ambler, J Baker, E Brown, L Butler, P Farr, D Dunnet, K Le Grand, D Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668, BIOORG MED, 8(24), 1998, pp. 3583-3588
Risultati: 1-8 |